Phase II study of sorafenib combined with gemcitabine and 5-fluorouracil in patients with metastatic renal cell carcinoma: Preliminary results

被引：0
|
作者：
Hongyun, L. [1 ]
Zhihong, C. [1 ]
Xiangqing, Y. [1 ]
Lu, S. [1 ]
Chuanliang, C. [1 ]
Xinan, S. [1 ]
Lin, S. [1 ]
Jun, G. [1 ]
机构：
[1] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16093
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Leucovorin, 5-fluorouracil, and gemcitabine: A phase I study
    Elizabeth Poplin
    John Roberts
    Marybeth Tombs
    Steven Grant
    Eric Rubin
    Investigational New Drugs, 1999, 17 : 57 - 61
  • [42] A Phase II trial of dosage escalation of sorafenib in Asian patients with metastatic renal cell carcinoma
    Wang, Hong-kai
    Zhang, Hai-liang
    Zhu, Yao
    Yao, Xu-dong
    Zhang, Shi-lin
    Dai, Bo
    Shen, Yi-jun
    Zhu, Yi-ping
    Shi, Guo-hai
    Qin, Xiao-jian
    Ma, Chun-guang
    Lin, Guo-wen
    Xiao, Wen-jun
    Ye, Ding-wei
    FUTURE ONCOLOGY, 2014, 10 (12) : 1941 - 1951
  • [43] Phase I/II study of arterial infusion with 5-fluorouracil combined with systemic gemcitabine for unresectable pancreatic cancer
    Tanaka, T.
    Nishiofuku, H.
    Sho, M.
    Anai, H.
    Sueyoshi, S.
    Yamamoto, K.
    Inaba, Y.
    Sakaguchi, H.
    Nakajima, Y.
    Kichikawa, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [44] Recombinant IL-21 in combination with sorafenib: Preliminary results from a phase I/II study in patients with metastatic renal cell cancer
    Bhatia, Shailender
    Curti, Brendan D.
    Gordon, Michael S.
    Quinn, David I.
    DeVries, Todd A.
    Hunder, Naomi N.
    Thompson, John A.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3354S - 3355S
  • [45] A Phase II Trial of Continuous 5-Fluorouracil in Recurrent or Metastatic Transitional Cell Carcinoma of the Urinary Tract
    Highley, M. S.
    Griffiths, G. O.
    Uscinska, B. M.
    Huddart, R. A.
    Barber, J. B. P.
    Parmar, M. K. B.
    Harper, P. G.
    CLINICAL ONCOLOGY, 2009, 21 (05) : 394 - 400
  • [46] A phase II trial of interferon-alpha and 5-fluorouracil in patients with advanced renal cell carcinoma - A Southwest Oncology Group Study
    Elias, L
    Blumenstein, BA
    Kish, J
    Flanigan, RC
    Wade, JL
    Lowe, BA
    Goodwin, JW
    Crawford, ED
    CANCER, 1996, 78 (05) : 1085 - 1088
  • [47] A phase II study of S-1 in combination with sorafenib in metastatic renal cell carcinoma
    Sakai, Hideki
    Ohba, Kojiro
    Hashine, Katsuyoshi
    Tomita, Yoshihiko
    Shinohara, Nobuo
    Fujisawa, Masato
    Eto, Masatoshi
    Ozono, Seiichiro
    Tsukamoto, Taiji
    Akaza, Hideyuki
    Naito, Seiji
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [48] A phase I trial of continuous infusion 5-fluorouracil and weekly gemcitabine: Updated results of an active combination for renal cell, hepatocellular and colon carcinoma
    Mani, S
    Gordon, G
    Vogelzang, NJ
    Bertucci, D
    Schilsky, RL
    Stadler, WM
    Ratain, MJ
    ANNALS OF ONCOLOGY, 1998, 9 : 165 - 165
  • [49] A phase II study of neoadjuvant gemcitabine/5-fluorouracil followed by 5-fluorouracil/oxaliplatin concurrent with radiation in patients with locally advanced pancreatic cancer.
    Lin, C.
    Kos, B. M.
    Sasson, A. R.
    Meza, J. L.
    Grem, J. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [50] Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-fluorouracil and infusional 5-fluorouracil alone in advanced pancreatic carcinoma patients -: Response
    Ducreux, M
    Mitry, E
    Ould-Kaci, A
    Boige, V
    Seitz, JF
    Bugat, R
    Breau, JL
    Bouché, O
    Etienne, PL
    Tigaud, JM
    Morvan, F
    Cvitkovic, E
    Rougier, P
    ANNALS OF ONCOLOGY, 2004, 15 (10) : 1577 - 1578
12345